Unitaid urges global community to enact three concrete measures to salvage progress against AIDS

On the second day of AFRAVIH, a Francophone international AIDS  conference in Geneva, UNITAID calls on the international community to implement three urgent measures to overcome obstacles in the progress against AIDS: reduce the effect of free trade agreements, tap into fresh sources of funding, such as a financial transaction tax, and promote treatment optimization […]

Continue Reading

Unitaid Warns Against Measures to Restrict Access to Medicines in EU-India FTA

In the lead up to Free Trade Agreement (FTA) discussions during the European Union-India Summit in New Delhi on 10 February, UNITAID urges both parties to ensure that access to medicines, and particularly AIDS medicines,is not hampered by trade interests via provisions that could undermine the production, registration and availability of generic medicines.  “This agreement […]

Continue Reading

UNITAID CONTINUES FUNDING FOR MEDICINES PATENT POOL AND PAEDIATRIC AIDS MEDICINES – Additional US$ 50 Million Allotted to Malaria

At its meeting in Paris on 12-13 December, the UNITAID Executive Board demonstrated its continued commitment to scaling up access for HIV/AIDS and malaria by allocating an extra US$ 138 million to the two diseases. UNITAID will provide funding support over the next four years for the Medicines Patent Pool to negotiate voluntary licences from […]

Continue Reading

UNITAID Landmark Report on HIV Diagnostics Hails a New Decade of Innovation and Access for Developing World – Diagnostics key to the HIV/AIDS Response

In the lead-up to the United Nations High Level Meeting on AIDS, next week, UNITAID today releases a landmark report revealing that innovative technologies to test and monitor HIV/AIDS could soon be within reach of the world’s poorest regions.   HIV/AIDS Diagnostic Landscape maps the development and imminent coming to market of a wide range of […]

Continue Reading

ESTHERAID : le premier programme de partenariat entre ESTHER et UNITAID

ESTHER lance au Bénin son projet ESTHERAID, dont l’objectif est d’améliorer l’accès aux traitements antirétroviraux, dans 5 pays : Bénin, Burkina Faso, Cameroun, Mali et République Centrafricaine. L’accès aux traitements ARV pour tous les patients, adultes et enfants nécessitant un traitement précoce et régulièrement suivi, demeure un enjeu primordial. Trop de patients sont encore éloignés […]

Continue Reading

Shréis Scalene awarded Federal QTDP grant to advance use of the CYTOTRON

The CYTOTRON is a Rotational Field Quantum Magnetic Resonance device to treat cancer and improve drug targeting and delivery… Shréis Scalene Sciences LLC, an Organization de Scalene member company, today announced that it has been awarded a cash grant of about a quarter million USD, under the U.S. Government’s Qualifying Therapeutic Discovery Project (“QTDP”) program, […]

Continue Reading